Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.
Open | $3.220 |
Close | $2.880 |
Volume / Avg. | 161.095K / 213.308K |
Day Range | 2.820 - 3.250 |
52 Wk Range | 1.280 - 5.510 |
Market Cap | $206.121M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 7.23% |
Days to Cover | 12.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Century Therapeutics (NASDAQ: IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
The latest price target for Century Therapeutics (NASDAQ: IPSC) was reported by Piper Sandler on Friday, April 12, 2024. The analyst firm set a price target for 9.00 expecting IPSC to rise to within 12 months (a possible 183.02% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $3.18 last updated April 25, 2024 at 5:24 PM EDT.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.